Study on pharmacokinetics of radioactive labelled defibrotide after oral or intravenous administration in rats

Thrombosis Research

Volumn 81, Issue 1, 1996, Pages 55-63

  Fisher, Jackie ^a   Holland, Terry K ^a   Pescador, Rodolfo ^b   Porta, Roberto ^b   Ferro, Laura ^b  

^a Inveresk Research   (United Kingdom)

^b Crinos Biological Research Laboratories   (Italy)

Author keywords

Defibrotide Bioavailability; Defibrotide Pharmacokinetics; Oral Administration; 125I Defibrotide; 32P Defibrotide

Indexed keywords

DEFIBROTIDE; IODINE 125; PHOSPHORUS 32;

ANIMAL EXPERIMENT; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; FIBRINOLYSIS; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 0030058306     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(95)00213-8     Document Type: Article

References (29)

1. PESCADOR, R., MANTOVANI, M., PRINO, G., MADONNA, M. Pharmacokinetics of Defibrotide and of its profibrinolytic activity in the rabbit. Thromb. Res. 30, 1-11, 1983.
2. JAMIESON, A., ALCOCK, P., WOOD, L., TUFFIN, D.P. Induction of profibrinolytic and anti-thrombotic activity in the rat following treatment with the deoxyribonucleic acid derivative Defibrotide. XIIIth Congress of the International Society on Thrombosis and Haemostasis, Amsterdam, 30 June-6 July, 1991. Abstract n. 2162. Thromb. Haemost. 65, 1292, 1991.
3. KLÖCKING, H.P. Pharmakologische Beeinflussung der Freisetzung von t-PA aus dem Gefäßendothel. Hämostaseologie 11, 76-88, 1991.
4. KLÖCKING, H.P. Acute t-PA release by Defibrotide. Thromb. Res. 66, 779-785, 1992.
5. NIADA, R., MANTOVANI, M., PRINO, G., PESCADOR, R., BERTI, F., OMINI, C., FOLCO, G.C. Antithrombotic activity of a polydeoxyribonucleotidic substance extracted from mammalian organs: a possible link with prostacyclin. Thromb. Res. 23, 233-246, 1981.
6. FUMAGALLI, G., ANGELACCIO, E., LOMBARDO, N., CLEMENTI, F. Morphometric and ultrastructural study of experimental venous thrombosis. Effects of Defibrotide, an antithrombotic agent. Haemostasis 17, 361-370, 1987.
7. PORTA, R., PESCADOR, R., MANTOVANI, M., NIADA, R., PRINO, G. Thrombolytic activity of Defibrotide against 1-,3-,7-, or 10-day-old venous thrombi in the rabbit. Fibrinolysis 4 (Suppl. 2), 27-31, 1990.
8. NIADA, R., PORTA, R., PESCADOR, R., MANTOVANI, M., PRINO, G. Cardioprotective effects of Defibrotide in acute myocardial ischemia in the cat. Thromb. Res. 38, 71-81, 1985.
9. NIADA, R., PORTA, R., PESCADOR, R., MANTOVANI, M., PRINO, G. Protective activity of Defibrotide against lethal acute myocardial ischemia in the cat. Thromb. Res. 42, 363-374, 1986.
10. LÖBEL, P., SCHRÖR, K. Selective stimulation of coronary vascular PGI2 but not of platelet thromboxane formation by Defibrotide in the platelet perfused heart. Naunyn Schmiedebergs Arch.Pharmacol. 331, 125-130, 1985.
11. THIEMERMANN, C., LÖBEL, P., SCHROR, K. Usefulness of Defibrotide in Protecting Ischemic Myocardium from Early Reperfusion Damage. Am. J. Cardiol. 56, 978-982, 1985.
12. BERTI, F., ROSSONI, G., OMINI, C., FOLCO, G.C., DAFFONCHIO, L., VIGANO', T., VIGANO', C. Defibrotide, an antithrombotic substance which prevents myocardial contracture in ischemic rabbit heart. Eur. J. Pharmacol. 135, 375-382, 1987.
13. BERTI, F., ROSSONI, G., MAGNI, F., CARUSO, D., OMINI, C., PUGLISI, L., GALLI, G. Nonsteroidal antiinflammatory drugs aggravate acute myocardial ischemia in the perfused rabbit heart: a role for prostacyclin. J. Cardiovasc. Pharmacol. 12, 438-444, 1988.
14. THIEMERMANN, C., THOMAS, G.R., VANE, J.R. Defibrotide reduces infarct size in a rabbit model of experimental myocardial ischaemia and reperfusion. Br. J. Pharmacol. 97, 401-408, 1989.
15. SCHRÖR, K., ACKERMANN, G., HOHLFELD, Th., LÖBEL, P., NEY, P., SCHRÖDER, H., STROBACH, H. Endothelial protection by Defibrotide - a new strategy for treatment of myocardial infarction?. Z. Kardiol. 78 (Suppl. 6). 35-41, 1989.
16. LEFER, A.M., AOKI, N. and MULLOY, D. Coronary-endothelium protective effects of defibrotide in ischaemia and reperfusion. Naunyn Schmiedebergs Arch. Pharmacol. 341, 246-250, 1990.
17. HOHLFELD, Th, STROBACH, H., SCHRÖR, K. Stimulation of prostacyclin synthesis by Defibrotide: improved contractile recovery from myocardial "stunning". J. Cardiovasc. Pharmacol., 17, 108-115, 1991.
18. ++ overloading. Thromb. Res. 65, 13-26, 1992.
19. COCCHERI, S., BIAGI, G. Defibrotide. Cardiovasc. Drug Rev. 9, 172-196, 1991.
20. BITTERMAN, H., LEFER, D.J., LEFER, A.M. Novel mechanism of action of a prostacyclin enhancing agent in haemorrhagic shock. Naunyn Schmiedebergs Arch. Pharmacol. 337, 679-686, 1988.
21. AOKI, N., SIEGFRIED, M., TSAO, P., LENTO, P., LEFER, A.M. "Beneficial mechanism of action of a prostacyclin enhancing agent in splanchnic artery occlusion shock. Res.Commun.Chem. Pathol. Pharmacol., 60, 275-289, 1988.
22. MA, X.L., PORTA, R., PESCADOR, R., LEFER, A.M. Novel beneficial mechanism of Defibrotide, a prostacyclin enhancing agent in splanchnic artery occlusion and reperfusion in rats. Meth. Find. Exp. Clin. Pharmacol. 13, 667-674, 1991.
23. LÖBEL, P., SCHRÖR, K. Stimulation of vascular prostacyclin and inhibition of platelet function by oral Defibrotide in cholesterol-fed rabbits. Atherosclerosis, 80, 69-79, 1989.
24. PESCADOR, R., PORTA, R., CONZ, A., MANTOVANI, M., PRINO, G. Defibrotide decreases cholesterol amount in hypercholesterolemic rabbit aorta, with no modification of plasma or lipoprotein cholesterol. Life Sci., 44, 789-797, 1989.
25. FISHER, J., JOHNSTON, A.M., HOLLAND, T.K., McCALLUM, J., PESCADOR, R., MANTOVANI, M., PRINO, G. Pharmacokinetics, absorption, distribution and disposition of 1251-Defibrotide following intravenous or oral administration in the rat. Thromb. Res. 70, 77-90, 1993
26. GIBALDI, M. Biopharmaceutics and clinical pharmacokinetics. 1991. Lea e Febiger, Philadelphia, 1991, Chapter 12 Pharmacokinetic Variability - Body Weight, Age, Sex and genetic factors, 234-271.
27. JAQUES, L.B., HIEBERT, L.M., WICE, S.M. Evidence from endothelium of gastric absorption of heparin and of dextran sulfates 8000. J. Lab. Clin. Med. 117, 122-130, 1991.
28. NOTARI, R.E., DE YOUNG, J.L. ANDERSON, R.C. Biopharmaceutics and Pharmacokinetics an introduction. New York: Marcel Dekker Inc., 1975.
29. TETTAMANTI, R., ALBERICO, P. BIANCHI, G., PESCADOR, R., PORTA, R., MANTOVANI, M., PRINO, G. Effects of renal or hepatic exclusion from systemic blood circulation on the pharmacokinetics of Defibrotide. XXV Congresso Nazionale della Societè Italiana di Farmacologia (Taormina - Giardini Naxos, 14-18 Ottobre 1990). Pharmacol. Res. 22, 477, 1990.